127 related articles for article (PubMed ID: 11092670)
1. Magnetic resonance spectroscopy evidence of abnormal cardiac energetics in Xp21 muscular dystrophy.
Crilley JG; Boehm EA; Rajagopalan B; Blamire AM; Styles P; Muntoni F; Hilton-Jones D; Clarke K
J Am Coll Cardiol; 2000 Nov; 36(6):1953-8. PubMed ID: 11092670
[TBL] [Abstract][Full Text] [Related]
2. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy.
Beer M; Seyfarth T; Sandstede J; Landschütz W; Lipke C; Köstler H; von Kienlin M; Harre K; Hahn D; Neubauer S
J Am Coll Cardiol; 2002 Oct; 40(7):1267-74. PubMed ID: 12383574
[TBL] [Abstract][Full Text] [Related]
3. Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy.
Hoogerwaard EM; Ginjaar IB; Bakker E; de Visser M
Neurology; 2005 Dec; 65(12):1984-6. PubMed ID: 16380627
[TBL] [Abstract][Full Text] [Related]
4. Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies.
Mavrogeni SI; Markousis-Mavrogenis G; Papavasiliou A; Papadopoulos G; Kolovou G
Methods Mol Biol; 2018; 1687():31-42. PubMed ID: 29067654
[TBL] [Abstract][Full Text] [Related]
5. Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls.
Grain L; Cortina-Borja M; Forfar C; Hilton-Jones D; Hopkin J; Burch M
Neuromuscul Disord; 2001 Mar; 11(2):186-91. PubMed ID: 11257476
[TBL] [Abstract][Full Text] [Related]
6. Muscle MRS detects elevated PDE/ATP ratios prior to fatty infiltration in Becker muscular dystrophy.
Wokke BH; Hooijmans MT; van den Bergen JC; Webb AG; Verschuuren JJ; Kan HE
NMR Biomed; 2014 Nov; 27(11):1371-7. PubMed ID: 25196814
[TBL] [Abstract][Full Text] [Related]
7. Na
Bkaily G; Jacques D
Can J Physiol Pharmacol; 2017 Oct; 95(10):1213-1223. PubMed ID: 28727929
[TBL] [Abstract][Full Text] [Related]
8. Cardiac Involvement Classification and Therapeutic Management in Patients with Duchenne Muscular Dystrophy.
Fayssoil A; Abasse S; Silverston K
J Neuromuscul Dis; 2017; 4(1):17-23. PubMed ID: 28269790
[TBL] [Abstract][Full Text] [Related]
9. Reduced cytosolic acidification during exercise suggests defective glycolytic activity in skeletal muscle of patients with Becker muscular dystrophy. An in vivo 31P magnetic resonance spectroscopy study.
Lodi R; Kemp GJ; Muntoni F; Thompson CH; Rae C; Taylor J; Styles P; Taylor DJ
Brain; 1999 Jan; 122 ( Pt 1)():121-30. PubMed ID: 10050900
[TBL] [Abstract][Full Text] [Related]
10. Cardiac assessment in duchenne and becker muscular dystrophies.
Romfh A; McNally EM
Curr Heart Fail Rep; 2010 Dec; 7(4):212-8. PubMed ID: 20857240
[TBL] [Abstract][Full Text] [Related]
11. Myocardial Fibrosis and Left Ventricular Dysfunction in Duchenne Muscular Dystrophy Carriers Using Cardiac Magnetic Resonance Imaging.
Lang SM; Shugh S; Mazur W; Sticka JJ; Rattan MS; Jefferies JL; Taylor MD
Pediatr Cardiol; 2015 Oct; 36(7):1495-501. PubMed ID: 25976773
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of cardiomyopathy in Duchenne and Becker's muscular dystrophy.
Sultan A; Fayaz M
J Ayub Med Coll Abbottabad; 2008; 20(2):7-13. PubMed ID: 19385447
[TBL] [Abstract][Full Text] [Related]
13. Dystrophin genotype-cardiac phenotype correlations in Duchenne and Becker muscular dystrophies using cardiac magnetic resonance imaging.
Tandon A; Jefferies JL; Villa CR; Hor KN; Wong BL; Ware SM; Gao Z; Towbin JA; Mazur W; Fleck RJ; Sticka JJ; Benson DW; Taylor MD
Am J Cardiol; 2015 Apr; 115(7):967-71. PubMed ID: 25702278
[TBL] [Abstract][Full Text] [Related]
14. Brain and heart magnetic resonance imaging/spectroscopy in duchenne muscular dystrophy.
Mavrogeni S; Pons R; Nikas I; Papadopoulos G; Verganelakis DA; Kolovou G; Chrousos GP
Eur J Clin Invest; 2017 Dec; 47(12):. PubMed ID: 28981141
[TBL] [Abstract][Full Text] [Related]
15. Precordial R wave height does not correlate with echocardiographic findings in boys with Duchenne muscular dystrophy.
Thrush PT; Edward N; Flanigan KM; Mendell JR; Allen HD
Congenit Heart Dis; 2013; 8(6):561-7. PubMed ID: 23510265
[TBL] [Abstract][Full Text] [Related]
16. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.
Neubauer S; Horn M; Cramer M; Harre K; Newell JB; Peters W; Pabst T; Ertl G; Hahn D; Ingwall JS; Kochsiek K
Circulation; 1997 Oct; 96(7):2190-6. PubMed ID: 9337189
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous abnormalities of in-vivo left ventricular calcium influx and function in mouse models of muscular dystrophy cardiomyopathy.
Greally E; Davison BJ; Blain A; Laval S; Blamire A; Straub V; MacGowan GA
J Cardiovasc Magn Reson; 2013 Jan; 15(1):4. PubMed ID: 23324314
[TBL] [Abstract][Full Text] [Related]
18. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
[TBL] [Abstract][Full Text] [Related]
19. Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: an in vivo 31P magnetic resonance spectroscopy study.
Lodi R; Rajagopalan B; Blamire AM; Cooper JM; Davies CH; Bradley JL; Styles P; Schapira AH
Cardiovasc Res; 2001 Oct; 52(1):111-9. PubMed ID: 11557239
[TBL] [Abstract][Full Text] [Related]
20. Early Detection of Myocardial Bioenergetic Deficits: A 9.4 Tesla Complete Non Invasive 31P MR Spectroscopy Study in Mice with Muscular Dystrophy.
Cui W; Jang A; Zhang P; Thompson B; Townsend D; Metzger JM; Zhang J
PLoS One; 2015; 10(8):e0135000. PubMed ID: 26262993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
